Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLDX | AMGN | BMY | GILD | VRTX |
| Company | Celldex Therapeutics | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 41.92 | 300.12 | 44.00 | 65.57 | 413.33 |
| High | 42.56 | 307.57 | 44.22 | 65.61 | 425.65 |
| Low | 40.72 | 298.89 | 43.56 | 64.76 | 412.12 |
| Last | 41.21 | 307.31 | 43.67 | 64.92 | 418.82 |
| Change | -1.00 | +7.01 | -0.37 | -0.54 | +8.58 |
| % Change | -2.37% | +2.33% | -0.84% | -0.82% | +2.09% |
| Volume | 397,200 | 2,859,500 | 11,928,300 | 5,134,900 | 1,651,600 |
| 20-Day Average Volume | 601,350 | 2,869,700 | 14,406,595 | 7,463,450 | 1,133,780 |
| Previous Close | 42.21 | 300.30 | 44.04 | 65.46 | 410.24 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 39.12 | 277.32 | 46.39 | 66.30 | 399.69 |
| 20-Day Raw Stochastic | 72.21% | 75.31% | 4.65% | 12.57% | 80.28% |
| 20-Day Relative Strength | 53.00% | 65.94% | 28.89% | 32.77% | 59.98% |
| Weighted Alpha | +7.21 | +32.33 | -36.84 | -21.04 | +21.35 |
| Today's Opinion | 56% Buy | 56% Buy | 100% Sell | 100% Sell | 56% Buy |
| Previous Opinion | 72% Buy | 40% Buy | 100% Sell | 100% Sell | 32% Buy |
| Last Month's Opinion | 56% Buy | 8% Sell | 16% Sell | 100% Sell | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.73% since 05/01/24 | +10.79% since 05/01/24 | -1.22% since 05/01/24 | -0.90% since 05/01/24 | +4.15% since 05/01/24 |
| Low | 38.75 on 05/02/24 | 274.90 on 05/02/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 394.03 on 05/07/24 |
| High | 43.35 on 05/07/24 | 322.60 on 05/03/24 | 44.62 on 05/06/24 | 66.14 on 05/07/24 | 425.65 on 05/08/24 |
| 1-Month | |||||
| %Chg | +3.70% since 04/08/24 | +14.16% since 04/08/24 | -14.54% since 04/08/24 | -6.48% since 04/08/24 | +3.61% since 04/08/24 |
| Low | 35.65 on 04/26/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 43.35 on 05/07/24 | 322.60 on 05/03/24 | 51.68 on 04/09/24 | 69.95 on 04/09/24 | 425.65 on 05/08/24 |
| 3-Month | |||||
| %Chg | +9.83% since 02/08/24 | +4.23% since 02/08/24 | -10.35% since 02/08/24 | -12.03% since 02/08/24 | -1.00% since 02/08/24 |
| Low | 35.03 on 02/13/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 53.18 on 03/04/24 | 322.60 on 05/03/24 | 55.03 on 03/13/24 | 76.21 on 03/11/24 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | +55.51% since 11/08/23 | +12.46% since 11/08/23 | -16.69% since 11/08/23 | -16.66% since 11/08/23 | +11.10% since 11/08/23 |
| Low | 25.08 on 11/09/23 | 260.52 on 11/21/23 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 341.90 on 11/16/23 |
| High | 53.18 on 03/04/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,359,581 | 161,091,424 | 89,273,480 | 81,502,736 | 106,030,224 |
| Shares Outstanding, K | 55,901 | 536,435 | 2,027,100 | 1,245,077 | 258,459 |
| Annual Sales | 6,880,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -141,430,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 4,130,000 | 7,447,000,000 | 11,865,000,000 | 6,686,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -43,310,000 | -113,000,000 | -11,911,000,000 | -4,170,000,000 | 968,800,000 |
| 60-Month Beta | 1.60 | 0.60 | 0.45 | 0.22 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.57 on 02/26/24 | 3.96 on 05/02/24 | -4.40 on 04/25/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.08 | 41.81 | 16.26 | 26.73 |